- Home
- RGA vs ILMN Comparison
RGA vs ILMN Comparison
Compare RGA & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGA
- ILMN
- Stock Information
- Founded
- RGA 1973
- ILMN 1998
- Country
- RGA United States
- ILMN United States
- Employees
- RGA N/A
- ILMN N/A
- Industry
- RGA Life Insurance
- ILMN Medical Specialities
- Sector
- RGA Finance
- ILMN Health Care
- Exchange
- RGA Nasdaq
- ILMN Nasdaq
- Market Cap
- RGA 13.0B
- ILMN 13.1B
- IPO Year
- RGA 1993
- ILMN 2000
- Fundamental
- Price
- RGA $196.55
- ILMN $109.30
- Analyst Decision
- RGA Buy
- ILMN Buy
- Analyst Count
- RGA 13
- ILMN 17
- Target Price
- RGA $243.75
- ILMN $124.35
- AVG Volume (30 Days)
- RGA 335.2K
- ILMN 2.3M
- Earning Date
- RGA 07-31-2025
- ILMN 07-31-2025
- Dividend Yield
- RGA 1.81%
- ILMN N/A
- EPS Growth
- RGA N/A
- ILMN N/A
- EPS
- RGA 11.84
- ILMN N/A
- Revenue
- RGA $21,030,000,000.00
- ILMN $4,337,000,000.00
- Revenue This Year
- RGA $7.28
- ILMN N/A
- Revenue Next Year
- RGA $10.33
- ILMN $3.15
- P/E Ratio
- RGA $16.60
- ILMN N/A
- Revenue Growth
- RGA 1.82
- ILMN N/A
- 52 Week Low
- RGA $159.25
- ILMN $68.70
- 52 Week High
- RGA $233.81
- ILMN $156.66
- Technical
- Relative Strength Index (RSI)
- RGA 50.36
- ILMN 73.79
- Support Level
- RGA $191.00
- ILMN $92.25
- Resistance Level
- RGA $198.20
- ILMN $99.34
- Average True Range (ATR)
- RGA 3.75
- ILMN 3.61
- MACD
- RGA 0.17
- ILMN 0.66
- Stochastic Oscillator
- RGA 68.67
- ILMN 95.79
About RGA Reinsurance Group of America Incorporated
Reinsurance Group of America Inc is an insurance holding company with operations in the United States, Latin America, Canada, Europe, Africa, Asia, and Australia. The core products and services include life reinsurance, living benefits reinsurance, group reinsurance, health reinsurance, financial solutions, facultative underwriting, and product development. The company's operations are divided into traditional and financial solution businesses.
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.